The Canada Patient Monitoring Devices Market was valued at $324.3 Million in 2026 and projected to reach to $372.3 Million by 2031, representing a compound annual growth rate of CAGR 4.4%. Canada's patient monitoring devices market is experiencing steady growth driven by an aging demographic, increasing chronic disease prevalence, and healthcare system pressures to reduce in-patient care costs.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Canada's patient monitoring devices market is valued at $324.3 million in 2026 and is projected to reach $372.3 million by 2031, growing at a CAGR of 4.4%, outpacing many developed markets in adoption velocity.
Canada's publicly funded healthcare system is increasingly integrating remote monitoring technologies to reduce hospital readmissions and manage chronic disease burden, particularly in aging populations across provinces.
Health Canada's streamlined approval pathways for digital health devices and strong data privacy frameworks under PIPEDA create a favorable environment for patient monitoring device manufacturers and distributors.
Rising incidence of diabetes, cardiovascular disease, and respiratory conditions in Canada is driving demand for continuous monitoring solutions, with provincial health authorities prioritizing remote care infrastructure investments.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | ASIA PACIFIC (Product) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 6.4% from 2026 to 2031 |
| Largest Segment | GENERAL WARDS (End User) |
| Market Size Base Year (Billions) | ~USD 55.81 (2026) |
| Revenue Forecast (Billions) | ~USD 76.11 (2031) |
| Segments Covered | End User, Type, Product |
3 segment dimensions are covered across the global market.
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ASCS | 317.3 | 333.1 | 350.3 | 369.1 | 389.5 | 411.7 | 436 | 462.5 | 5.7 |
| HOME CARE SETTINGS | 188.5 | 200.3 | 213.3 | 227.4 | 243 | 260 | 278.7 | 299.3 | 7 |
| HOSPITALS & CLINICS | 960.4 | 1004.2 | 1051.7 | 1103.5 | 1159.8 | 1221.1 | 1287.8 | 1360.5 | 5.3 |
| OTHER END USERS | 90 | 93.2 | 96.6 | 100.3 | 104.4 | 108.8 | 113.6 | 118.8 | 4.2 |
| TOTAL | 1556.3 | 1630.8 | 1711.9 | 1800.3 | 1896.6 | 2001.6 | 2116.1 | 2241.2 | 5.5 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ROCHE HOLDING AG | Switzerland | Public Company | Oncology & Haematology Pharma,Immunology, Inflammatory & Autoimmune Pharma,Neuroscience, Ophthalmology & Other Specialty Pharma, |
| LIFEWATCH AG | Switzerland | Private Company | Mobile Cardiac Telemetry (MCT) solutions,Cardiac event monitoring devices and services,Holter monitoring solutions, |
| HONEYWELL | United States | Public Company | Industrial Automation,Building Automation,Energy and Sustainability Solutions (UOP and related), |
| SIEMENS AG | Germany | Public Company | Digital Industries (automation, PLM, industrial software),Smart Infrastructure (electrification, building tech, grid),Mobility (rail systems, automation, services), |
| HALMA PLC | United Kingdom | Public Company | Safety,Environmental & Analysis,Healthcare, |
| AT&S | Canada | Public Company | Turnkey automated manufacturing and assembly systems,Pre- and post-automation services,Software and digital solutions, |
| CONMED CORPORATION | United States | Public Company | Orthopedic sports medicine and soft tissue repair,Powered instruments (Hall large and small bone systems),General surgery (AirSeal, Buffalo Filter, endomechanical, electrosurgical), |
| GODREJ GROUP | India | Private Company | Home appliances (refrigerators, washing machines, ACs, microwaves, coolers, disinfecting appliances),Commercial appliances (medical refrigerators, deep freezers, personal cooling, disinfecting),Locks, architectural hardware, security products, and kitchen fittings, |
| ALTRAN | France | Private Company | Engineering and R&D services,Organization and IT systems consulting, |
| MEDTRONIC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes), |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices,Diagnostic Products,Nutritional Products, |
| DEXCOM, INC. | United States | Public Company | Dexcom G7 and G7 15 Day CGM systems,Dexcom G6 CGM system,Dexcom ONE+ and value-focused CGM, |
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS), |
| NIHON KOHDEN CORPORATION | Japan | Public Company | Patient monitors and clinical information systems,Physiological measuring equipment (EEG/ECG/EMG and diagnostics),Defibrillators, AEDs, ventilators, anesthesia and therapeutic devices, |
| MINDRAY MEDICAL INTERNATIONAL LTD. | China | Private Company | Patient Monitoring and Life Support Products,In-Vitro Diagnostic Products,Medical Imaging Systems, |
| BD | United States | Public Company | Medical Essentials (syringes, needles, IV catheters, sharps, basic disposables),Connected Care (infusion pumps, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery, prefillable syringes, related systems), |
| GETINGE AB | Sweden | Public Company | Acute Care Therapies (ICU, ECMO, ventilation, monitoring, drainage),Surgical Workflows (OR equipment, anesthesia, OR integration, sterile supply management),Life Science (sterilization, biocontainment, bioprocess, labware cleaning), |
| DRäGERWERK AG & CO. KGAA | Germany | Public Company | Acute care devices (ventilators, anaesthesia, monitoring),Hospital infrastructure and perinatal care,Safety technology (gas detection, respiratory, PPE), |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (coronary, structural heart, CRM, peripheral),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention),MedSurg – Urology and Pelvic Health, |
| MASIMO CORPORATION | United States | Private Company | SET pulse oximetry (core monitors and sensors),Rainbow SET Pulse CO-Oximetry and advanced noninvasive monitoring,Brain function and hemodynamic monitoring solutions, |
| OMRON CORPORATION | Japan | Public Company | Industrial automation (sensors, safety, motion, robotics, power supplies, automation systems),Device and module solutions (relays, switches, connectors, sensors for devices),Healthcare (cardiovascular, respiratory, pain management, remote patient monitoring), |
Roche Holding AG is a Swiss pharmaceutical and diagnostics company founded in 1896 that operates as a public company with approximately 103,249 employees.
LifeWatch AG is a Swiss private company established in 2001 with 640 employees operating in the healthcare sector.
Honeywell is a United States-based public company founded in 1885 with approximately 101,000 employees operating across diversified industrial and technology sectors.
Siemens AG is a German multinational public company founded in 1847 with 310,312 employees, operating in engineering, manufacturing, and technology sectors.
Halma PLC is a United Kingdom-based public company founded in 1894 with 9,000 employees specializing in safety, environmental, and infrastructure solutions.
AT&S is a Canadian public company founded in 1978 with 7,000 employees providing services in the technology and infrastructure sectors.
CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees specializing in medical technology and surgical equipment.
Godrej Group is an Indian private company founded in 1897 with 13,316 employees operating across consumer goods, real estate, and industrial sectors.
Altran is a French private company founded in 1970 with 50,124 employees providing engineering and technology consulting services.
Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees specializing in medical devices and healthcare technology.
Abbott Laboratories is a United States-based public company founded in 1888 with 115,000 employees operating in pharmaceuticals, diagnostics, and nutritional products.
DexCom, Inc. is a United States-based public company founded in 1999 with 11,050 employees specializing in continuous glucose monitoring systems.
GE Healthcare is a United States-based public company established in 2022 with 54,000 employees providing medical imaging and healthcare technology solutions.
Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees specializing in medical electronic equipment and monitoring systems.
Mindray Medical International Ltd. is a Chinese private company founded in 1991 with 8,400 employees manufacturing medical devices and diagnostic equipment.
BD is a United States-based public company founded in 1897 with 72,000 employees specializing in medical devices, diagnostics, and life sciences.
Getinge AB is a Swedish public company founded in 1904 with 11,754 employees providing medical technology and healthcare solutions.
Drägerwerk AG & Co. KGaA is a German public company founded in 1889 with 16,033 employees specializing in medical and safety technology.
Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees manufacturing medical devices and equipment.
Masimo Corporation is a United States-based private company founded in 1989 with 2,200 employees specializing in patient monitoring and medical technology.
Omron Corporation is a Japanese public company founded in 1933 with 26,050 employees operating in automation, healthcare, and electronic components.
The Middle East& Africa patient monitoring devices market is valued at $324.3 million in 2026.
Middle East& Africa's patient monitoring devices market is forecast to reach $372.3 million by 2031.
The Middle East& Africa patient monitoring devices market is growing at a CAGR of 4.4% from 2026 to 2031.
Middle East& Africa's market growth is driven by healthcare digitalization, rising chronic disease prevalence, telemedicine expansion, and supportive regulatory frameworks.
Wearable and portable patient monitoring devices are experiencing the highest demand in Middle East& Africa due to their convenience and effectiveness in remote care delivery.
The study involved major activities in estimating the current market size for the patient monitoring devices market. Exhaustive secondary research was done to collect information on the patient monitoring devices market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the patient monitoring devices market.
This research study involved the extensive use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and Companies House documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the patient monitoring devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/Managing Directors, Marketing Heads/Directors, Sales Directors, Marketing/Sales Managers, Regional/Area Sales Managers, Export/Import Heads/Managers, and Other Market-Related Personnel from various companies and organizations operating in the patient monitoring devices market. Primary sources from the demand side included Law Enforcement Agencies, Vice Presidents, C-level Executives, Department Heads, Enterprises, Individuals, Supply Management Team of Hospitals, Clinic Personnel, and Laboratory Technicians.
Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
Note 2: Other primary roles include sales, marketing, and product management.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the patient monitoring devices market. These methods were also used extensively to estimate the sizes of various market subsegments. The research methodology used to estimate the market size includes the following:

The entire market was split into two segments when the market size was determined. Data triangulation and market breakdowns were used as needed to complete the market engineering process and derive precise statistics for all segments.
pproach for deriving the market size and estimating market growth.
sing secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of patient monitoring devices. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Patient monitoring devices continuously measure and track physiological parameters to manage various medical conditions, including cardiovascular diseases, diabetes, respiratory disorders, neurological conditions, and critical care situations, providing real-time insights into patient health.
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Patient Monitoring Devices Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report